2022TiP Stereotactic treatment with neoadjuvant radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV)
Authors:
- T. ZhangTZT. Zhang
- S. WolduSWS. Woldu
- Q. QinQQQ. Qin
- S. ColeSCS. Cole
- W. ArafatWAW. Arafat
- C. JiangCJC. Jiang
- J. WangJWJ. Wang
- K. CourtneyKCK. Courtney
- A. DeVilbissADA. DeVilbiss
- R. PloskiRPR. Ploski
- R. HannanRHR. Hannan
- D. YangDYD. Yang
- 17 September 2024
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 35, S1165